11.2 Long-Term Care Pharmacy & Emergency Drug Supply

11.2 Long-Term Care Pharmacy & Emergency Drug Supply

Quick Answer: Long-Term Care Facility (LTCF) pharmaceutical care is governed by Tennessee Board of Pharmacy Rule Chapter 1140-14 and federal CMS regulations (42 CFR § 483.45). Every facility must utilize a licensed consultant pharmacist who conducts a mandatory monthly Drug Regimen Review (DRR) for every resident, reporting all irregularities in writing to the attending physician and Director of Nursing. Psychotropic medications (antipsychotics, sedatives) are strictly regulated: they cannot be used as chemical restraints, must undergo Gradual Dose Reduction (GDR) (twice during the first year; annually thereafter), and PRN psychotropics are capped at 14 days without clinical renewal. Controlled substance emergency kits remain the legal property of the DEA-registered provider pharmacy under 21 CFR § 1301.27. Finally, discontinued controlled substances in an LTCF cannot be returned to stock; they must be destroyed on-site, witnessed and documented by two licensed healthcare professionals, with logs maintained for at least 2 years.

---

1. Regulatory Framework: Tennessee Rule Chapter 1140-14 & Federal CMS Mandates

Pharmaceutical services provided to residents of Long-Term Care Facilities (LTCFs)—such as skilled nursing facilities (SNFs), nursing homes, and intermediate care facilities—operate under a dual regulatory structure combining Tennessee administrative law and rigorous federal oversight:

1. State Legal Authority: Rules of the Tennessee Board of Pharmacy, Tenn. Comp. R. & Regs. Chapter 1140-14 ("Long-Term Care Pharmacy Practice Sites"), governing pharmacy permits, drug packaging, emergency kits, and medication delivery.
2. Federal Legal Authority: Centers for Medicare & Medicaid Services (CMS) Conditions of Participation for Long-Term Care Facilities, codified at 42 CFR § 483.45 ("Pharmacy Services"). Federal CMS standards are enforceable in all facilities receiving Medicare or Medicaid funding.

Inpatient Chart Orders vs. Outpatient Dispensing in LTCFs

Unlike acute hospital inpatients whose medications are stored centrally and dispensed from an internal hospital pharmacy, LTCF residents receive pharmaceuticals primarily from an outside closed-door long-term care provider pharmacy:

• Prescriber Orders: Medications are dispensed based on lawful chart orders or direct electronic/written prescriptions issued by the resident's attending physician, nurse practitioner, or physician assistant.
• Unit-Dose Packaging: Under Board Rule 1140-14, medications are routinely packaged in blister cards (e.g., 30-day "bingo cards"), unit-dose strip packaging, or cassette modules to facilitate scheduled nursing administration.
• Labeling Requirements: Labels must display the resident's full name, prescriber's name, pharmacy name and address, prescription/order serial number, drug name, strength, dosage form, route, explicit administration directions, lot number, and expiration date/beyond-use date.

---

2. The Consultant Pharmacist & Mandatory Monthly Drug Regimen Review (DRR)

Under both Tennessee Rule 1140-14 and 42 CFR § 483.45(c), every long-term care facility must retain a qualified licensed pharmacist to serve as its consultant pharmacist.

The Mandatory Monthly DRR

• Frequency: The consultant pharmacist must conduct a comprehensive Drug Regimen Review (DRR) for each individual resident at least once every month (monthly).
• Clinical Scope: The DRR evaluates the resident's complete medical chart, laboratory values, vital signs, and diagnostic indicators to ensure the medication regimen is free from:
  • Unnecessary Drugs: Medications administered in excessive doses, for excessive durations, without adequate clinical indications, or in the presence of adverse consequences.
  • Drug-Drug & Drug-Disease Interactions: Harmful interactions, duplicative therapies, or contraindications with underlying comorbidities.
  • Inadequate Monitoring: Failure to order and assess necessary monitoring parameters (e.g., serum creatinine for renally cleared drugs, potassium and digoxin levels, INR for warfarin, blood glucose/A1c for antidiabetic therapy).
  • Adverse Drug Events: Unrecognized adverse drug reactions masquerading as new medical conditions (the "prescribing cascade").

Mandatory Written Reporting & Attending Physician Action

When the consultant pharmacist identifies any drug irregularity during the monthly DRR:

1. Immediate Written Report: The consultant pharmacist must document the finding in a formal written DRR report and submit it directly to:
   • The resident's attending physician
   • The facility's Director of Nursing (DON)
   • The facility administrator
2. Attending Physician Response Mandate: Under 42 CFR § 483.45, the attending physician is legally required to document that they have reviewed the consultant pharmacist's report. The physician must affirmatively document:
   • The specific clinical action taken (e.g., reducing the dose, discontinuing the medication, or ordering confirmatory lab tests); OR
   • A detailed clinical rationale explaining why no change is being made and why continued therapy at the current regimen is medically necessary.

┌─────────────────────────────────────────────────────────────────────────────┐
│                     MONTHLY DRUG REGIMEN REVIEW (DRR)                       │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. Consultant Pharmacist Audits Medical Record (Once Monthly per Resident)  │
│    └─> Screens for unnecessary drugs, excessive dosing, interactions, labs  │
│                                                                             │
│ 2. Pharmacist Identifies Drug Irregularity                                  │
│    └─> Drafts formal written DRR recommendation report                     │
│    └─> Delivers report to Attending Physician, Director of Nursing & Admin  │
│                                                                             │
│ 3. Attending Physician Review & Documented Action                           │
│    └─> Documents acceptance (orders change/discontinuation)                 │
│    └─> OR documents explicit clinical justification if recommendation denied│
└─────────────────────────────────────────────────────────────────────────────┘

---

3. Psychotropic Medication Stewardship & Gradual Dose Reduction (GDR)

Because vulnerable geriatric residents in nursing facilities have historically been subjected to inappropriate chemical restraints to manage behavioral disturbances, federal and state regulations impose strict safeguards on psychotropic drug usage.

Definition of Psychotropic Medications

Under 42 CFR § 483.45(c)(3), any drug that affects brain activities associated with mental processes and behavior is classified as a psychotropic drug. This encompasses four primary classes:

1. Antipsychotics (e.g., haloperidol, risperidone, quetiapine, olanzapine)
2. Anti-anxiety agents / Anxiolytics (e.g., lorazepam, alprazolam, buspirone)
3. Sedatives and Hypnotics (e.g., zolpidem, temazepam, eszopiclone)
4. Antidepressants (e.g., sertraline, escitalopram, mirtazapine, trazodone)

Clinical Safeguards & Antipsychotic Prohibitions

• No Chemical Restraints: Psychotropic medications must never be administered for the convenience of facility staff, for discipline, or as a chemical restraint.
• Specific Diagnosed Condition Required: Residents who have not previously used psychotropic medications cannot receive them unless therapy is medically necessary to treat a specific, clinically diagnosed condition documented in the medical record.
• Black Box Warning Compliance: Antipsychotic therapy in elderly patients with dementia-related psychosis carries an FDA black-box warning for increased mortality; their use requires rigorous documentation of distressing neuropsychiatric symptoms that pose danger to the resident or others.

Gradual Dose Reduction (GDR) Protocols

CMS regulations establish strict, binding timelines for attempting Gradual Dose Reduction (GDR)—systematically tapering the dose down to determine whether the medication can be discontinued or maintained at a lower effective dose:

┌─────────────────────────────────────────────────────────────────────────────┐
│                    CMS GRADUAL DOSE REDUCTION (GDR) TIMELINE                │
├──────────────────────┬──────────────────────────────────────────────────────┤
│ Year 1 of Therapy    │ Must attempt GDR in TWO SEPARATE QUARTERS            │
│                      │ (Minimum 1 month between reduction attempts)         │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Subsequent Years     │ Must attempt GDR at least ANNUALLY (once per year)   │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Clinical Exception   │ Prescriber must document why GDR is clinically       │
│                      │ contraindicated (e.g., prior failed taper caused     │
│                      │ acute relapse, severe self-harm, or psychosis)       │
└──────────────────────┴──────────────────────────────────────────────────────┘

PRN Psychotropic Orders Capped at 14 Days

• Strict 14-Day Limit: PRN (as-needed) orders for psychotropic medications are strictly limited to a maximum of 14 days.
• Renewal Requirements: After 14 days, the order automatically expires and cannot be refilled or renewed unless the attending physician directly evaluates the resident, assesses the underlying clinical status, and documents the clinical rationale for writing a new 14-day PRN order.
• Antipsychotic PRN Rule: For PRN antipsychotics, the prescriber must evaluate the resident in person (or via direct clinical examination) before issuing a renewal beyond 14 days.

---

4. Emergency Medication Kits in LTCFs (Non-Controlled vs. Controlled)

Because long-term care facilities do not house on-site compounding pharmacies, emergency drug kits are placed on nursing units to manage acute medical events before the off-site provider pharmacy can deliver scheduled doses.

Non-Controlled Emergency Drug Kits

• Joint Approval: The contents, dosage forms, and maximum allowable quantities of medications in non-controlled emergency kits are jointly determined and approved in writing by the facility's medical director, Director of Nursing, and the consultant pharmacist.
• Security & Housing: Emergency kits must be maintained in a locked room, locked medication cart, or locked wall cabinet under the direct custody of licensed nursing personnel.
• Tamper-Evident Seals: Kits must be sealed with a tamper-evident indicator (numbered plastic breakaway seal) or secured within an electronically audited cabinet.
• Exterior Labeling: The exterior surface of the kit must bear an attached label listing all contained medications, strengths, quantities, and the earliest expiration date of ANY component contained within the kit.

Controlled Substance Emergency Kits in LTCFs (DEA 21 CFR § 1301.27)

Under the federal Controlled Substances Act, a long-term care facility is not registered as a DEA practitioner or pharmacy. Therefore, an LTCF cannot purchase, hold title to, or store controlled substances independently. However, under federal DEA regulations (21 CFR § 1301.27) and Tennessee Board rules, an authorized provider pharmacy may place a Controlled Substance Emergency Kit in an LTCF under strict conditions:

---

5. Medication Returns, Disposal & Two-Person Witnessed Destruction

When an LTCF resident is discharged, transferred to an acute hospital, or passes away, or when a medication expires or is discontinued, facilities accumulate unused pharmaceuticals. Disposal is subject to stringent anti-diversion and environmental rules.

The General Prohibition: No Return to Stock

• Core Rule: Under Tennessee law, once a legend or controlled medication has been dispensed and delivered to an LTCF, it has left the closed custody of the pharmacy. It CANNOT be returned to the provider pharmacy stock for reuse or re-dispensing to another patient.
• Adulteration & Integrity Risks: Because the provider pharmacy cannot verify continuous temperature, humidity, and sanitary controls while medications resided in the nursing facility, returning them to commercial inventory would constitute drug adulteration under TCA § 53-10-101.
• Limited Board Exception for Non-Controlled Packaging: Under specific Tennessee Board rules and TennCare return programs, non-controlled medications in unopened, sealed, tamper-evident unit-dose blister packages or original manufacturer unit-dose packaging that have never left institutional custody may be eligible for credit/return, provided drug integrity is certified by a pharmacist.

On-Site Destruction of Controlled Substances (Two-Person Witness Mandate)

Controlled substances that have been discontinued, partially used, expired, or left by deceased residents cannot be surrendered to unauthorized staff or returned to retail pharmacy stock. They must be destroyed directly on-site at the LTCF:

┌─────────────────────────────────────────────────────────────────────────────┐
│            LTCF CONTROLLED SUBSTANCE ON-SITE DESTRUCTION PROTOCOL           │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. Identification & Quarantine                                              │
│    └─> Discontinued/expired controlled drug quarantined in double-locked box │
│                                                                             │
│ 2. Two-Person Witnessed Physical Destruction                                │
│    └─> Must be witnessed and executed by TWO LICENSED PROFESSIONALS         │
│        (e.g., Consultant Pharmacist + Director of Nursing / Licensed RN)    │
│    └─> Render drug non-retrievable (chemical neutralizing agent/incinerate) │
│                                                                             │
│ 3. Destruction Log Recordkeeping                                            │
│    └─> Resident name, prescription number, drug name, strength, exact dose, │
│        quantity destroyed, date, disposal method, and BOTH SIGNATURES       │
│    └─> Retention mandate: Maintained at facility for at least 2 YEARS       │
└─────────────────────────────────────────────────────────────────────────────┘

• Alternative Disposal Method: Facilities may also dispose of controlled substances by transferring them to an authorized DEA-registered Reverse Distributor using official DEA transfer forms (or utilizing authorized DEA collector collection receptacles pursuant to the Secure and Responsible Drug Disposal Act of 2010).

---

6. Acute Hospital vs. Long-Term Care Facility: Comparison Table

---

7. Practical Exam Scenarios

Scenario 1: Unlawful PRN Psychotropic Renewal

Case: A 78-year-old nursing home resident with vascular dementia is prescribed lorazepam 0.5 mg PO PRN anxiety. The order has been in effect for 28 consecutive days, with doses administered three times per week. The nursing staff contacts the provider pharmacy requesting a refill. The consultant pharmacist reviews the chart and notes that the attending physician has not evaluated the resident since the initial order was written. Legal Analysis: Under 42 CFR § 483.45 and Board guidelines, PRN orders for psychotropic medications are strictly capped at 14 days. Because the attending physician did not re-evaluate the resident and document the clinical rationale for continuing therapy, the order is legally invalid. The pharmacy cannot dispense a refill, and the consultant pharmacist must cite the irregularity on the monthly DRR report to the physician and DON.

Scenario 2: Accessing Controlled Substance Emergency Kit

Case: At 11:00 PM on a Saturday, an LTCF resident in severe pain following a fall requires an emergency dose of morphine. The provider pharmacy is closed and delivery is 3 hours away. The attending physician calls the charge nurse and provides a verbal emergency order for Morphine 10 mg IM stat. The charge nurse unlocks the controlled substance emergency kit, removes one ampule, administers the dose, and documents the withdrawal on the kit's log sheet. Legal Analysis: This action is entirely lawful under DEA 21 CFR § 1301.27 and Tennessee Board rules. The controlled emergency kit is placed in the facility specifically for emergency situations where delay would harm the resident. Nursing accessed the kit pursuant to a valid prescriber emergency order, recorded full withdrawal details, and will notify the provider pharmacy for replenishment and prescription reconciliation.

Scenario 3: Controlled Substance Disposal Witnessing

Case: A resident who was receiving oxycodone 5 mg tablets passes away. The resident's family brings the remaining 24 tablets to the nursing station. The charge nurse and a pharmacy delivery driver flush the tablets down the toilet, sign a piece of paper, and file it in the administrative office. Legal Analysis: This disposal violates multiple federal and state laws. First, flushing pharmaceuticals into municipal wastewater is environmentally prohibited. Second, controlled substance destruction in an LTCF must be witnessed and documented by two licensed healthcare professionals (e.g., the consultant pharmacist and DON/RN). A delivery driver is not a licensed healthcare professional. The disposal must render the medication non-retrievable (using chemical neutralizing packets or reverse distribution) and be documented on formal destruction logs retained for 2 years.